C - Chemistry – Metallurgy – 07 – F
Patent
C - Chemistry, Metallurgy
07
F
C07F 9/117 (2006.01) A61K 31/66 (2006.01) A61K 31/70 (2006.01)
Patent
CA 2166154
A method for the treatment of, or prevention of a disease and/or condition in a patient which is treatable or preventable by receptor mediated treatment is provided, the method comprising the administration of an effective amount of a medicine and/or therapeutic agent with an effective amount of a binding agent (other than hyaluronan, a pharmaceutically acceptable salt thereofor other such forms of hyaluronic acid) which binding agent is mixed with the medicine and/or therapeutic agent and which binding agent binds at the site of the disease or condition with at least one of the group of binding domains selected from: (a) RSHKTRSHH {Single-Letter Code of Amino Acids} also identified as: Arg-Ser-His-Lys-Thr-Arg-Ser-His-His {Three-Letter Code of Amino Acids} also identified as: CGC-TCG-CAC-AAG-ACC-AGG-TCG-CAC-CAC (Another Code) (b) RPHFHKR {Single Letter Code of Amino Acids} also identified as: Arg-Pro-His-Phe-His-Lys-Arg {Three-Letter Code of Amino Acids} also identified as: CGG-CCC-CAC-TTC-CAC-AAG-CGG (Another Code)
Jagotec Ag
Ogilvy Renault
LandOfFree
Binding agents and the use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Binding agents and the use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Binding agents and the use thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2055038